Ivermectin for COVID-19 prophylaxis
dc.contributor.author | Hegazy, Abdelmonem Awad | |
dc.date.accessioned | 2021-11-02T09:37:05Z | |
dc.date.available | 2021-11-02T09:37:05Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | European Journal of Clinical and Experimental Medicine T. 19, z. 3 (2021), s. 280–282 | pl_PL.UTF-8 |
dc.identifier.doi | 10.15584/ejcem.2021.3.15 | |
dc.identifier.eissn | 2544-1361 | |
dc.identifier.issn | 2544-2406 | |
dc.identifier.uri | http://repozytorium.ur.edu.pl/handle/item/6862 | |
dc.language.iso | eng | pl_PL.UTF-8 |
dc.publisher | Wydawnictwo Uniwersytetu Rzeszowskiego | pl_PL.UTF-8 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | Ivermectin for COVID-19 prophylaxis | pl_PL.UTF-8 |
dc.type | letter | pl_PL.UTF-8 |